1
|
Abrahão NM, Guimarães GC, Tamanini JB, Costa SFDO, Ferreira PJDM, Silva VARD, Castilho AM. Neuroendocrine adenoma of middle ear: a case report and endoscopic approach. Braz J Otorhinolaryngol 2024; 90:101432. [PMID: 38735198 PMCID: PMC11107194 DOI: 10.1016/j.bjorl.2024.101432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 02/29/2024] [Accepted: 03/23/2024] [Indexed: 05/14/2024] Open
Affiliation(s)
- Nicolau Moreira Abrahão
- Universidade de Campinas, Faculdade de Ciências Médicas, Departamento de Otorrinolaringologia, Campinas, SP, Brazil.
| | - Guilherma Correa Guimarães
- Universidade de Campinas, Faculdade de Ciências Médicas, Departamento de Otorrinolaringologia, Campinas, SP, Brazil
| | - Jonas Belchior Tamanini
- Universidade de Campinas, Faculdade de Ciências Médicas, Departamento de Otorrinolaringologia, Campinas, SP, Brazil
| | - Sofia Fontes de Oliva Costa
- Universidade de Campinas, Faculdade de Ciências Médicas, Departamento de Otorrinolaringologia, Campinas, SP, Brazil
| | | | | | - Arthur Menino Castilho
- Universidade de Campinas, Faculdade de Ciências Médicas, Departamento de Otorrinolaringologia, Campinas, SP, Brazil
| |
Collapse
|
2
|
Engel MSD, van der Lans RJL, Jansen JC, Leemans CR, Bloemena E, Lissenberg-Witte BI, Rijken JA, Smit CF, Hensen EF. Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review. Oral Oncol 2021; 121:105465. [PMID: 34352556 DOI: 10.1016/j.oraloncology.2021.105465] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Revised: 07/12/2021] [Accepted: 07/13/2021] [Indexed: 11/26/2022]
Abstract
Middle ear adenomatous neuroendocrine tumours (MEANTs) are rare, unpredictable tumours. Although most MEANTs are characterized by a benign biological behaviour and indolent growth pattern, some studies have reported locally invasive and metastastic disease. Currently, the optimal management strategy for MEANTs remains subject of debate. The aim of this study is to review the literature on MEANTs with focus on its clinical characteristics, treatment strategies and outcome. A systematic review was conducted using PubMed, Embase and Cochrane databases. A total of 111 studies comprising 198 patients with MEANT were included. Treatment modalities comprised surgery (90%), surgery with adjuvant radiotherapy (9%) and palliative (chemo)radiotherapy in (1%). Local recurrence was observed in 25% of the patients and 7% of the patients developed metastasis, over a median period of 5.7 years (range 7 months - 32 years). Twelve of 13 patients (92%) who developed metastases had a local recurrence. Four patients (2%) died of MEANT: three due to distant metastases and one due to extensive local recurrence. Reliable histopathologic predictors of outcome could not be identified. These findings indicate that the clinical presentations of MEANT vary substantially, the overall recurrence rate is considerable and initial local tumour control is paramount. Because of the unpredictable clinical course, prolonged follow-up is warranted.
Collapse
Affiliation(s)
- M S D Engel
- Department of Otolaryngology & Head and Neck Surgery, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - R J L van der Lans
- Department of Otolaryngology & Head and Neck Surgery, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - J C Jansen
- Department of Otorhinolaryngology & Head and Neck Surgery, Leiden University Medical Center, Leiden, the Netherlands
| | - C R Leemans
- Department of Otolaryngology & Head and Neck Surgery, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - E Bloemena
- Department of Pathology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - B I Lissenberg-Witte
- Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| | - J A Rijken
- Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - C F Smit
- Department of Otolaryngology & Head and Neck Surgery, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
| | - E F Hensen
- Department of Otorhinolaryngology & Head and Neck Surgery, Leiden University Medical Center, Leiden, the Netherlands
| |
Collapse
|
3
|
Almuhanna K. "Neuroendocrine adenoma of the middle ear with the history of otitis media and carcinoma of the cheek: a case report". BMC Res Notes 2014; 7:532. [PMID: 25123111 PMCID: PMC4147159 DOI: 10.1186/1756-0500-7-532] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2013] [Accepted: 07/30/2014] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Neuroendocrine adenomas of the middle ear are rare benign tumors deriving from middle ear mucosal cell with both neuroendocrine and epithelial properties. Approximately one hundred cases have been reported in the literature. Here we report a patient with neuroendocrine adenoma of the middle ear with the history of otitis media; the patient earlier had received radiotherapy for the treatment of basal cell carcinoma. CASE PRESENTATION A 49- year- old Saudi man presented with a progressive hearing loss and fullness in the left ear with the history of otitis media for which he had undergone myringotomy and ventilating tubes insertion. Earlier at the age of 45 years this patient was given radiotherapy for the treatment of basal cell carcinoma in his cheek. The otoscopy showed a protruded external ear mass obscuring the tympanic membrane. Microscopy and histological examination suggested an endocrine adenoma of the middle ear. The computerized tomography scan of the temporal bone showed an extensive soft tissue mass without any osteolysis. Histological and immunohistochemical examination following surgical excision confirmed the diagnosis of neuroendocrine adenoma of the middle ear. CONCLUSION A rare case of neuroendocrine adenoma of the middle ear with earlier history of otitis media and carcinoma of the cheek is presented here. Surgical excision of mass resulted in uneventful recovery. Although the etiologic factors leading to the disease is far from clear, the role of radiotherapy given for the treatment of basal cell carcinoma may not be ruled out.
Collapse
Affiliation(s)
- Khabti Almuhanna
- Department of Otolyringoscopy, Prince Sultan Military Medical City Hospital, Riyadh, Saudi Arabia.
| |
Collapse
|
4
|
Marchioni D, Alicandri-Ciufelli M, Gioacchini FM, Bonali M, Presutti L. Transcanal endoscopic treatment of benign middle ear neoplasms. Eur Arch Otorhinolaryngol 2013; 270:2997-3004. [DOI: 10.1007/s00405-013-2371-x] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2012] [Accepted: 01/17/2013] [Indexed: 12/16/2022]
|
5
|
|
6
|
|